Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDL42
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $98,274.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on August 28, 2025, carries an ultimate completion date of September 19, 2025, and includes no set-aside designation. The contract represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contract awards from the Defense Logistics Agency. The company's portfolio encompasses an extensive range of medications and medical products, from specialty pharmaceuticals to over-the-counter items, with delivery to military health facilities nationwide. This particular delivery order for Keytruda, an oncology therapeutic, exemplifies the company's capability to supply critical branded pharmaceutical products directly to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FDL42?
SPE2DB25FDL42 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FDL42 worth?
The government has obligated $98,275 on SPE2DB25FDL42.
Is contract SPE2DB25FDL42 an order under another contract?
Yes. SPE2DB25FDL42 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL42 competed?
The extent of competition for SPE2DB25FDL42 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award